Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2013, Article ID 702831, 4 pages
http://dx.doi.org/10.1155/2013/702831
Case Report

A Case of Philadelphia Chromosome Positive Myeloproliferative Neoplasm in a Pregnant Woman with Unusual Primary Myelofibrosis Features

1Division of Hematopathology, Department of Pathology and Laboratory Medicine, University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77555, USA
2Division of Hematology and Oncology, Department of Internal Medicine, University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77555, USA

Received 18 April 2013; Accepted 11 May 2013

Academic Editors: S. Aref, K. Kawauchi, K. Nakase, P. Tsirigotis, and S. D. Wagner

Copyright © 2013 Jason Koshy et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Jabbour and H. Kantarjian, “Chronic myeloid leukemia: 2012 update on diagnosis, monitoring, and management,” American Journal of Hematology, vol. 87, no. 11, pp. 1037–1045, 2012. View at Google Scholar
  2. C. V. Cotta and C. E. Bueso-Ramos, “New insights into the pathobiology and treatment of chronic myelogenous leukemia,” Annals of Diagnostic Pathology, vol. 11, no. 1, pp. 68–78, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Mishra, M. Mahapatra, R. Kumar et al., “Philadelphia-chromosome positive thrombocythemia in a child,” European Journal of Haematology, vol. 75, no. 3, pp. 262–263, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Rice and U. Popat, “Every case of essential thrombocythemia should be tested for the Philadelphia chromosome,” American Journal of Hematology, vol. 78, no. 1, pp. 71–73, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Tulpule, S. Bewley, S. E. Robinson, D. Radia, C. Nelson-Piercy, and C. N. Harrison, “The management and outcome of four pregnancies in women with idiopathic myelofibrosis,” British Journal of Haematology, vol. 142, no. 3, pp. 480–482, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. C. N. Harrison and S. E. Robinson, “Myeloproliferative disorders in pregnancy,” Hematology/Oncology Clinics of North America, vol. 25, no. 2, pp. 268–269, 2011. View at Google Scholar
  7. F. Chen, C. Zhang, W. Wang et al., “A case of Philadelphia-chromosome positive chronic idiopathic myelofibrosis,” Leukemia Research, vol. 32, no. 4, pp. 665–667, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Bose, M. Deininger, J. Gora-Tybor, J. M. Goldman, and J. V. Melo, “The presence of typical and atypical BCR-ABL fusion genes in leukocytes of normal individuals: biologic significance and implications for the assessment of minimal residual disease,” Blood, vol. 92, no. 9, pp. 3362–3367, 1998. View at Google Scholar · View at Scopus
  9. M. Bornhäuser, B. Mohr, U. Oelschlaegel et al., “Concurrent JAK2(V617F) mutation and BCR-ABL translocation within committed myeloid progenitors in myelofibrosis,” Leukemia, vol. 21, no. 8, pp. 1824–1826, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Jallades, S. Hayette, I. Tigaud et al., “Emergence of therapy-unrelated CML on a background of BCR-ABL-negative JAK2V617F-positive chronic idiopathic myelofibrosis,” Leukemia Research, vol. 32, no. 10, pp. 1608–1610, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Laibe, Z. Tadrist, C. Arnoulet, D. Sainty, and M. J. Mozziconacci, “A myeloproliferative disorder may hide another one,” Leukemia Research, vol. 33, no. 8, pp. 1133–1136, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. V. Gupta, L. Foltz, S. Sirhan, L. Busque, and A. R. Turner, “Emerging therapeutic options for myelofibrosis: a Canadian perspective,” American Journal of Blood Research, vol. 2, no. 3, pp. 170–186, 2012. View at Google Scholar
  13. A. V. Jones, S. Kreil, K. Zoi et al., “Widespread occurrence of the JAKsub>2 V617F mutation in chronic myeloproliferative disorders,” Blood, vol. 106, no. 6, pp. 2162–2168, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. P. H. Y. Lily and G. M. Keating, “Ruxolitinib,” Drugs, vol. 72, no. 16, pp. 2117–2127, 2012. View at Google Scholar
  15. T. Barbui and G. Finazzi, “Special issues in myeloproliferative neoplasms,” Current Hematologic Malignancy Reports, vol. 6, no. 1, pp. 28–35, 2011. View at Google Scholar